Clavubactin vet. (3.75 - 5kg)

25 x 10 pc

Tablet

Active substance

Amoxicillin (Amoxicillin trihydrate) : 50 mg

Clavulanic acid (Potassium clavulanate) : 12,5 mg

ATC code

QJ01CR02 Amoxicillin and beta-lactamase inhibitor

QJ01CR Comb. of penicillins, incl. beta-lactamase inhibitors

QJ01C Beta-lactam antibacterials, penicillins

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Dogs and cats

Indications

Treatment of infections in cats and dogs caused by bacteria sensitive to amoxicillin in combination with clavulanic acid, particularly:

- Skin infections (including superficial and deep pyodermas) associated with Staphylococci (including beta-lactamase producing strains) and Streptococci.

- Urinary tract infections associated with Staphylococci (including beta-lactamase producing strains), Streptococci, Escherichia coli (including beta-lactamase producing strains), Fusobacterium necrophorum and Proteus spp.

- Respiratory tract infections associated with Staphylococci (including betalactamase producing strains), Streptococci and Pasteurellae.

- Gastrointestinal tract infections associated with Escherichia coli (including betalactamase producing strains) and Proteus spp.

- Infections of the oral cavity (mucous membrane) associated with Clostridia,

Corynebacteria, Staphylococci (including beta-lactamase producing strains), Streptococci, Bacteroides spp (including beta-lactamase producing strains), Fusobacterium necrophorum and Pasteurellae.

Dose to be administered and administration route

Posology

For oral administration in dogs and cats.

To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing.

Dosage

The recommended dose is 12.5 mg of combined active substance (=10 mg amoxicillin and 2.5 mg clavulanic acid) per kg bodyweight, twice daily.

The following table is intended as a guide to dispensing the product at the standard dose rate of 12.5 mg of combined actives per kg bodyweight twice daily.

	Number of tablets twice daily
Bodyweight (kg)	amoxicilline 50 mg/ clavulanic acid 12.5 mg	amoxicilline 250 mg/ clavulanic acid 62.5 mg	amoxicilline 500 mg/ clavulanic acid 125 mg
1 – 1.25
1.25 – 2.5
2.5 – 3.75
3.75 – 5
5 – 6.25
6.25 - 12.5
12.5 - 18.75
18.75 - 25
25 - 31.25
31.25 - 37.5
37.5 - 50
50 – 62.5
62.5 - 75

In refractory cases of skin infections, a double dose is recommended (25 mg per kg bodyweight, twice daily).

Duration of therapy

The majority of routine cases respond to 5 – 7 days of therapy.

In chronic cases, a longer case of therapy is recommended. In such circumstances overall treatment length must be at the clinician’s discretion, but should be long enough to ensure complete resolution of the bacterial disease.

Adverse reactions

Mild gastrointestinal symptoms (diarrhoea, nausea and vomiting) may occur after administration of the product.

Allergic reactions (skin reactions, anaphylaxia) may occasionally occur. In these cases, administration should be discontinued and a symptomatic treatment given.